Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004274 · ClinicalTrials.gov registry record · NA
Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
A NA study of Turner's Syndrome, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT00004274: Completed NA study of Turner's Syndrome, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00004274 is a NA study of Turner's Syndrome that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 260 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004274, a NA study of Turner's Syndrome, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced by girls with Turner's syndrome. PURPOSE: Clinical trial to study the effectiveness of long term estrogen therapy on mental and social functioning in girls who have Turner's syndrome.
Conditions Studied
Interventions
- DRUG Estrogen
Study Locations (1)
Pennsylvania
- Jefferson Medical College of Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 1990-02 |
| Phase | NA |
What the finished NCT00004274 record still lists
NCT00004274 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Turner's Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Estrogen is the first listed.
NCT00004274 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00004274 about?
NCT00004274 is a clinical study titled "Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome". RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced b...
What is the current status of trial NCT00004274?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 1990-02.
What conditions does trial NCT00004274 study?
This clinical trial studies the following conditions: Turner's Syndrome.
What interventions are being tested in trial NCT00004274?
The interventions under investigation include: Estrogen (DRUG).
Who is sponsoring clinical trial NCT00004274?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004274 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Turner's Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00004274's enrollment target sits among peer trials
260 397th of 2000 higher than 1,601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia